Identification of Mycobacterium tuberculosis clinical isolates with altered phagocytosis by human macrophages due to a truncated lipoarabinomannan.
Phenotypically distinct clinical isolates of Mycobacterium tuberculosis are capable of altering the balance that exists between the pathogen and human host and ultimately the outcome of infection. This study has identified two M. tuberculosis strains (i.e. HN885 and HN1554) among a bank of clinical isolates with a striking defect in phagocytosis by primary human macrophages when compared with strain Erdman, a commonly used laboratory strain for studies of pathogenesis. Mass spectrometry in conjunction with NMR studies unequivocally confirmed that both HN885 and HN1554 contain truncated and more branched forms of mannose-capped lipoarabinomannan (ManLAM) with a marked reduction of their linear arabinan (corresponding mainly to the inner Araf-alpha(1-->5)-Araf unit) and mannan (with fewer 6-Manp residues and more substitutions in the linear Manp-alpha(1-->6)-Manp unit) domains. The truncation in the ManLAM molecules produced by strains HN885 and HN1554 led to a significant reduction in their surface availability. In addition, there was a marked reduction of higher order phosphatidyl-myo-inositol mannosides and the presence of dimycocerosates, triglycerides, and phenolic glycolipid in their cell envelope. Less exposed ManLAM and reduced higher order phosphatidyl-myo-inositol mannosides in strains HN885 and HN1554 resulted in their low association with the macrophage mannose receptor. Despite reduced phagocytosis, ingested bacilli replicated at a fast rate following serum opsonization. Our results provide evidence that the clinical spectrum of tuberculosis may be dictated not only by the host but also by the amounts and ratios of surface exposed mycobacterial adherence factors defined by strain genotype.
Torrelles
Jordi B
JB
Center for Microbial Interface Biology, Division of Infectious Diseases, Department of Internal Medicine, Ohio State University, Columbus, Ohio 43210, USA.
Knaup
Rose
R
Kolareth
Avina
A
Slepushkina
Tatiana
T
Kaufman
Thomas M
TM
Kang
Peter
P
Hill
Preston J
PJ
Brennan
Patrick J
PJ
Chatterjee
Delphi
D
Belisle
John T
JT
Musser
James M
JM
Schlesinger
Larry S
LS
D002478:Cells, Cultured; D008401:Gas Chromatography-Mass Spectrometry; D006801:Humans; D008070:Lipopolysaccharides / Q000737:chemistry / Q000378:metabolism*; D008264:Macrophages / Q000378:metabolism*; D009682:Magnetic Resonance Spectroscopy; D008745:Methylation; D008970:Molecular Weight; D009169:Mycobacterium tuberculosis / Q000302:isolation & purification*; D010587:Phagocytosis
D008070:Lipopolysaccharides; C050016:lipoarabinomannan
J Immunol. 1999 Jun 1;162(11):6740-6
10352293
Biochem J. 1997 Oct 15;327 ( Pt 2):519-25
9359425
Proc Natl Acad Sci U S A. 1986 Apr;83(8):2501-5
3458213
Science. 2005 Aug 5;309(5736):941-3
16081738
Proc Natl Acad Sci U S A. 1997 Sep 2;94(18):9869-74
9275218
Nature. 1951 Jul 28;168(4265):167
14875032
J Immunol. 1990 Apr 1;144(7):2771-80
2108212
Proc Natl Acad Sci U S A. 2001 May 8;98(10):5752-7
11320211
J Biol Chem. 1992 Mar 25;267(9):6228-33
1556131
Glycobiology. 1994 Apr;4(2):165-73
8054716
J Gen Microbiol. 1993 Nov;139(11):2649-58
8277248
J Immunol. 1993 Apr 1;150(7):2920-30
8454864
Infect Immun. 2000 Oct;68(10):5619-27
10992462
Nature. 1999 Nov 4;402(6757):79-83
10573420
Microbiology (Reading). 2002 Oct;148(Pt 10):3049-3057
12368438
J Immunol. 1996 Nov 15;157(10):4568-75
8906835
Mol Microbiol. 1996 Nov;22(3):583-92
8939440
J Biol Chem. 2004 Sep 24;279(39):41227-39
15263002
Glycobiology. 1998 Feb;8(2):113-20
9451020
J Immunol. 2006 Aug 1;177(3):1805-16
16849491
Nature. 2004 Sep 2;431(7004):84-7
15343336
Glycoconj J. 1999 Jun;16(6):257-64
10579694
J Bacteriol. 2007 Apr;189(7):2583-9
17237171
Glycobiology. 1997 Sep;7(6):811-7
9376683
J Biol Chem. 2005 Feb 18;280(7):5651-63
15546869
N Engl J Med. 1998 Mar 5;338(10):633-9
9486991
Mol Microbiol. 2004 Jul;53(2):391-403
15228522
J Biol Chem. 1991 May 25;266(15):9652-60
1903393
Immunobiology. 2001 Dec;204(5):527-35
11846215
J Clin Microbiol. 1996 Aug;34(8):2007-10
8818900
Mol Microbiol. 2005 Nov;58(3):774-90
16238626
J Exp Med. 2005 Oct 3;202(7):987-99
16203868
J Biol Chem. 1993 Jun 15;268(17):12401-11
8509380
J Immunol. 1994 Apr 15;152(8):4070-9
8144972
J Biol Chem. 2001 Feb 9;276(6):3863-71
11073941
J Biol Chem. 1992 Mar 25;267(9):6234-9
1556132
J Biol Chem. 2008 May 9;283(19):12992-3000
18303028
Antimicrob Agents Chemother. 1994 Apr;38(4):773-80
8031045
Angew Chem Int Ed Engl. 2004 Jul 26;43(30):3918-22
15274213
Glycobiology. 1995 Feb;5(1):117-27
7772860